ARTICLE | Clinical News
Ortho-McNeil regulatory update
March 8, 1999 8:00 AM UTC
Ortho-McNeil received approval to market Regranex becaplermin platelet-derived growth factor (PDGF) in Canada to treat full thickness lower extremity diabetic ulcers. Chiron Corp. (CHIR, Emeryville,...